Literature DB >> 11578104

Improved activity and stability of lysozyme at the water/CH2Cl2 interface: enzyme unfolding and aggregation and its prevention by polyols.

C Pérez1, K Griebenow.   

Abstract

Protein inactivation and aggregation at the water/CH2Cl2 interface is one of the most detrimental events hindering the encapsulation of structurally unperturbed proteins into poly(lactide-co-glycolide) (PLG) microspheres for their clinical application as sustained release dosage forms. We have investigated the inactivation and aggregation of the model protein hen egg-white lysozyme at this interface and devised methods to prevent both events. When lysozyme was exposed to a large water/CH2Cl2 interface achieved by homogenization, lysozyme aggregation occurred. Fourier-transform infrared (FTIR) spectroscopic data demonstrated that the aggregates formed contained intermolecular beta-sheets. The aggregates were of a noncovalent nature because they slowly dissolved in D2O and the IR spectral bands typical for the intermolecular beta-sheets disappeared at approximately 1617 and 1690 cm(-1). The observed loss in specific enzyme activity of soluble lysozyme was caused by the irreversible formation of an unfolded lysozyme species, which was found to be monomeric, and was able to leave the water/CH2Cl2 interface and accumulate in the aqueous phase. Polyols were, in a concentration dependent fashion, efficient in ameliorating lysozyme unfolding and aggregation. However, prevention of lysozyme aggregation and activity loss in the various samples were unrelated. Thus, polyols must work by more than one mechanism preventing the two events. For the first time, an excipient effect on the conformational stability of lysozyme has been excluded from contributing to the prevention of lysozyme unfolding and aggregation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578104     DOI: 10.1211/0022357011776667

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.

Authors:  Sheetal S Pai; Robert D Tilton; Todd M Przybycien
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

3.  Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.

Authors:  Zahra Ghalanbor; Martin Körber; Roland Bodmeier
Journal:  Pharm Res       Date:  2009-12-23       Impact factor: 4.200

4.  Accelerating protein release from microparticles for regenerative medicine applications.

Authors:  Lisa J White; Giles T S Kirby; Helen C Cox; Roozbeh Qodratnama; Omar Qutachi; Felicity R A J Rose; Kevin M Shakesheff
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-02-21       Impact factor: 7.328

Review 5.  Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.

Authors:  Giuseppe Lofano; Corey P Mallett; Sylvie Bertholet; Derek T O'Hagan
Journal:  NPJ Vaccines       Date:  2020-09-18       Impact factor: 7.344

6.  Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres.

Authors:  Moraima Morales-Cruz; Giselle M Flores-Fernández; Myreisa Morales-Cruz; Elsie A Orellano; José A Rodriguez-Martinez; Mercedes Ruiz; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

Review 7.  Interfacial tension effects on the properties of PLGA microparticles.

Authors:  Andrew Otte; Farrokh Sharifi; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2020-08-23       Impact factor: 5.999

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.